Your browser doesn't support javascript.
loading
The MITRE trial protocol: a study to evaluate the microbiome as a biomarker of efficacy and toxicity in cancer patients receiving immune checkpoint inhibitor therapy.
Thompson, Nicola A; Stewart, Grant D; Welsh, Sarah J; Doherty, Gary J; Robinson, Matthew J; Neville, B Anne; Vervier, Kevin; Harris, Simon R; Adams, David J; Dalchau, Katy; Bruce, David; Demiris, Nikolaos; Lawley, Trevor D; Corrie, Pippa G.
Afiliação
  • Thompson NA; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Stewart GD; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Welsh SJ; Department of Surgery, University of Cambridge, Cambridge, UK.
  • Doherty GJ; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Robinson MJ; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Neville BA; Microbiotica, Chesterford Research Park, Cambridge, UK.
  • Vervier K; Microbiotica, Chesterford Research Park, Cambridge, UK.
  • Harris SR; Microbiotica, Chesterford Research Park, Cambridge, UK.
  • Adams DJ; Microbiotica, Chesterford Research Park, Cambridge, UK.
  • Dalchau K; Wellcome Sanger Institute, Cambridge, UK.
  • Bruce D; Cambridge Clinical Trials Unit - Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Demiris N; Cambridge Clinical Trials Unit - Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Lawley TD; Cambridge Clinical Trials Unit - Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Corrie PG; Microbiotica, Chesterford Research Park, Cambridge, UK.
BMC Cancer ; 22(1): 99, 2022 Jan 24.
Article em En | MEDLINE | ID: mdl-35073853
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Consórcios Microbianos / Microbioma Gastrointestinal / Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Consórcios Microbianos / Microbioma Gastrointestinal / Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article